Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | alisertib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.7 |
mRNA | MG-132 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.7 |